Empharma is a young and newly established pharmaceutical company with a wide vision, comprising highly educated and experienced professionals who contribute to its success.Empharma ilaç was established by combining both the know how and innovation. The owners who are the 4th generation of the Embil family have been actively involved in the Turkish pharmaceutical industry as well as being born in to a century long pharmaceutical experienced family. The DNA of Empharma ilaç was engineered by the combination of all these elements.
Mission
Our mission is to contribute to the pharmaceutical business globally with our years of experience via much needed cross border licensing and marketing, in Russia, CIS and Far East countries where we spent about 20 years of active involvement, through our hub in Istanbul,Turkey
Vision
Our vision is to serve the pharmaceutical business by developing original and innovative products by using our know-how where we would be involved in all stages of development starting from formulation, scale-up and R&D activities culminating in the registration, licensing and marketing of these products.
International Advisory Board
| Country | Name | Title |
|---|---|---|
|
USA |
Prof. Jack Sobel, MD |
Dean, School of Medicine and Professor of Internal Medicine (Infectious Disease) and Obstetrics and Gynecology, Wayne State University, Detroit, Michigan
|
|
|
Prof. Scott McClelland, MD, MPH |
Professor of Medicine, Epidemiology, and Global Health, University of Washington |
|
|
Sergio Nacht |
Co-Founder and Chief Scientific Officer at Riley Nacht LLC |
|
Germany |
Prof. Werner Mendling |
Obstetrician-gynecologist, Helios Kliniken GmbH, Wuppertal |
|
Russia |
Prof. Yuri Raifeld, Ph.D., Dr. Sci. |
Founder and President of Raifarm LLC, Moscow |
|
|
Prof. Eugeny Kira, MD |
Director, Obstetrics&Gynecology Department, PirogovNational Medical and Surgical Center, Moscow |
Business Partners
